Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Yuanxiang Technology | 2021 | Series A | $15.6M | Haidian |
| Mai Yi | 2021 | Series Unknown | $37.6M | Wuhan |
| Zhimeng Biopharma | 2021 | Series B | $54.7M | Pudong |
| Mint Health | 2021 | Series D | $15.6M | Naxxar |
| Holosensor Medical Technology | 2021 | Series Unknown | Undisclosed | Shanghai |
| KK Group | 2021 | Series F | $300.0M | Dongguan |
| RadRock Tech | 2021 | Series D | Undisclosed | Xiamen |
| Yunphant Blockchain | 2021 | Series B | $15.7M | Hangzhou |
| Tikin Media | 2021 | Series B | Undisclosed | Beijing |
| Hrain Biotechnology | 2021 | Series C | Undisclosed | Shanghai |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 176 | Yuanxiang Technology | Series A | $15.6M | Haidian, China |
| 177 | Mai Yi | Series Unknown | $37.6M | Wuhan, China |
| 178 | Zhimeng Biopharma | Series B | $54.7M | Pudong, China |
| 179 | Mint Health | Series D | $15.6M | Naxxar, Malta |
| 180 | Holosensor Medical Technology | Series Unknown | Undisclosed | Shanghai, China |
| 181 | KK Group | Series F | $300.0M | Dongguan, China |
| 182 | RadRock Tech | Series D | Undisclosed | Xiamen, China |
| 183 | Yunphant Blockchain | Series B | $15.7M | Hangzhou, China |
| 184 | Tikin Media | Series B | Undisclosed | Beijing, China |
| 185 | Hrain Biotechnology | Series C | Undisclosed | Shanghai, China |
Yuanxiang Technology is a high-tech enterprise providing intelligent stereo vision software and hardware integrated solutions & products.
Mai Yi is an IT company that develops cloud software products for the education, healthcare, finance, and transportation industries.
Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes.
Mint Health is a pharmaceutical product distributor and wholesaler.
Holosensor Medical Technology researches, develops, manufactures, and sells medical devices and in-vitro diagnostics.
KK Group provides an online-to-offline imported products marketplace.
RadRock Tech is an innovative RFIC design company.
Yunphant Blockchain is a blockchain service and product platform.
Tikin Media is a forward-looking advertising company that innovates building elevator media.
Hrain Biotechnology is adhering to the concept of treating diseases and saving people.
YuanHua Zhineng is a developer of orthopedic surgery robots.
HappyCast is a multi-screen interactive technology solution provider.
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.
Meishe Co,. Ltd is a Video and Audio Editing&Effect Solution Provider
GROOVE X is designing and developing a next-generation household robot that truly touches people's hearts and inspires real affection.
Transwarp develops big data software technologies for enterprises.
Yunwang Wandian is an eCommerce and online retail service.
LP Pharmaceuticals is a pharmaceutical company.
MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.
Encootech is a Digital Consulting and Digital Robot Solution Provider
Lachesis is a high-tech company that focuses on clinical applications and offers intelligent products and services to healthcare providers.
Haici Technology is a mobile platform for hospitals to connect patients, optimise hospital visits and streamline admin workflow.
Shangqiao Logistics is a logistics company that provides trucking, warehousing, and air-freight services.
Jiatui Technology is a Shenzhen based enterprise services company.
Golden Technology is a big data service company offering electronic invoice solutions using blockchain technology.
Shenzhen Capital Group has invested in 277 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Shenzhen Capital Group's top investment sectors include Health Care, Software, Biotechnology, Manufacturing, Information Technology. The firm invests across 49 different industry categories.
Among tracked funding rounds, Yunwang Wandian received $912.0M in a Series A round. Shenzhen Capital Group's total known invested capital is $5.7B.
Shenzhen Capital Group's average investment size is $32.2M across its portfolio of 277 companies.
Recent Shenzhen Capital Group portfolio additions include Yuanxiang Technology, Mai Yi, Zhimeng Biopharma, Mint Health, Holosensor Medical Technology. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors